Eikon Therapeutics

At Eikon Therapeutics, our Clinical team plays a vital role in translating groundbreaking discoveries into life-changing medicines for patients with unmet need including cancer and neurodegenerative diseases. With a commitment to patient-centered clinical excellence, we prioritize the well-being of participants in our clinical trials and strive to deliver high-quality data that supports the development of effective therapies. Our track record showcases our integrated capabilities to advance both in-licensed assets and those emerging from our proprietary platform. As part of #TeamEikon, you'll contribute to a vision that redefines the boundaries of science, driving innovation that has the potential to transform the lives of patients around the world. Explore West- and East-Coast opportunities to join our clinical team here: https://lnkd.in/g7V6b9RZ #ClinicalResearch #HealthcareInnovation #ScienceCareers

Navigating the complexities of clinical trial supply chains is more challenging than ever as the industry adapts to new technologies and ever-changing global regulations. On September 17, Eikon Therapeutics’ Senior Director of Clinical Supply Chain Reid Tonik will share insights on “Creating a Clinical Supply Chain Playbook for Onboarding Acquired Assets” at Clinical Trial Supply West Coast in San Francisco. Reid will cover best practices and actionable strategies including: ➡ Identifying priorities and guiding transition activities while mitigating risks to patient dosing and trial continuity in a culturally and personally mindful way. ➡ Deciding when and what to integrate, and assessing the impact on the acquired portfolio. ➡ Tools of the trade and lessons learned from past mistakes. We hope to see you there!   #TeamEikon #ClinicalTrials #ClinicalOperations #CTSWestCoast

We’re so proud of #TeamEikon for how they support and give back to our communities! Eikon’s Veterans Employee Resource Group (ERG) includes 11 veterans, military spouses, and military supporters. This recent partnership with Operation Homefront is the first of many events planned in the coming months where the group will be volunteering and showing support for our local military community.

We’re looking forward to the Morgan Stanley 22nd Annual Global Healthcare Conference on Sept. 4th in New York City. Eikon Therapeutics’ CEO Roger M. Perlmutter and CFO Alfred (Freddie) Bowie will present a business update on the company’s progress including recent advancements in the company’s pipeline and clinical development programs, as well as updates related to our Eikon Systems business. To access the archived recording after the event, visit the link in comments. 

"I’m excited about the prospect that new technological advances have afforded us to further accelerate innovative therapeutic development.” Ten years after playing an instrumental role in bringing Keytruda —one of the most impactful cancer therapies in history— to market, Roy Baynes, MD, PhD, now serves as Eikon Therapeutics' Chief Medical Officer. At Eikon, Roy is building one of the industry's most sophisticated clinical organizations and a therapeutic pipeline with the potential to deliver important new medicines to address serious illnesses that reflect areas of unmet medical need. In a recent podcast interview, Roy shared insights from his accomplished career and discussed what excites him most about the future of medicine, particularly the potential of new technologies and artificial intelligence. Catch the full interview and explore current opportunities to join Roy's growing clinical team at Eikon (links in comments). #TeamEikon #Biotech

We're looking forward to next week's Goldman Sachs Global Healthcare Conference, where our CEO, Roger M. Perlmutter, and CFO, Alfred (Freddie) Bowie, will be providing important business updates and highlighting the exciting progress of our lead clinical programs, along with key data presented at the recent #AACR24 and #ASCO24 meetings. To learn more and access an archived recording of the presentation, please visit: www.EikonTx.com/news. #TeamEikon #Biotech

If you’re keen to learn more about Eikon's progress over recent months, check us out at ASCO (and link below), follow on LinkedIn or leave a comment. #eikontx #science #engineering #therapeutics

Excited to connect with colleagues, collaborators, and the clinical oncology community at #ASCO24! #TeamEikon will be sharing updates from our EIK1001 and EIK1003 programs and hosting meetings at Exhibit Hall Booth 32116. Swing by and say hi! Discover more about our abstracts: https://lnkd.in/g2DP-vpu

#AI is top of mind across biopharma R&D organizations and Eikon CEO Roger Perlmutter will be on-site in New York City speaking to this important industry topic next week at the US #Pharma & #Biotech Summit hosted by Endpoints News and the Financial Times. With Andrew Dunn at the helm and a panel that includes Regeneron, Iambic Therapeutics, and Benchling, it's sure to be an engaging conversation! #FTPharma #TeamEikon

This Earth Day, #TeamEikon partnered with Save The Bay for a day of community volunteering in our own backyard at Eden Landing Ecological Reserve. Together, we cleared 480 pounds (!) of invasive weeds. It was not only productive but also incredibly enjoyable contributing positively to our beautiful Bay Area environment and collaborating with colleagues across different departments. A BIG thank you to everyone who brought their energy and community spirit to the day! It truly embodied the spirit of Eikon. #EarthDay #EarthMonth #CommunityService #LoveWhereYouWork #EiKare